Despite the international guidelines on the containment of the coronavirus disease 2019 (COVID-19) pandemic, the European scientific community was not sufficiently prepared to coordinate scientific efforts. To improve preparedness for future pandemics, we have initiated a network of nine European-funded Cooperation in Science and Technology (COST) Actions that can help facilitate inter-, multi-, and trans-disciplinary communication and collaboration.

Bioinformatics and Functional Genomics Group Cancer Research Center Consejo Superior de Investigaciones Científicas and University of Salamanca Campus Miguel de Unamuno ES 37007 Salamanca Spain

Cardiovascular Research Unit Department of Population Health Luxembourg Institute of Health L 1445 Strassen Luxembourg

CIQUP Department of Chemistry and Biochemistry Faculty of Sciences University of Porto PT 4169 007 Porto Portugal

CNR Consiglio Nazionale delle Ricerche IAC Istituto per le Applicazioni del Calcolo IT 00185 Rome Italy

CNR National Research Council of Italy Institute of Molecular Genetics Unit of Bologna IT 40136 Bologna Italy; IRCCS Istituto Ortopedico Rizzoli IT 40136 Bologna Italy

Department of Biology of the Cell Nucleus Institute of Molecular Genetics Czech Academy of Sciences CZ 14220 Prague Czech Republic

Department of Biosciences University of Durham Upper Mountjoy Science Site Durham DH1 3LE UK

Department of Blood Group Serology and Transfusion Medicine Medical University of Vienna AT 1090 Vienna Austria; Center for Physiology and Pharmacology Medical University of Vienna AT 1090 Vienna Austria; Center for Medical Statistics Informatics and Intelligent Systems Institute for Artificial Intelligence and Decision Support Medical University of Vienna AT 1090 Vienna Austria

Department of Oncology University of Turin IT 10126 Turin Italy

Department of Pharmacology and Personalised Medicine MeHNS FHML Maastricht University NL 6200 Maastricht The Netherlands

Department of Structural and Chemical Biology Centro de Investigaciones Biológicas Margarita Salas CSIC ES 28040 Madrid Spain

Dipartimento di Scienze della Salute Università Magna Græcia di Catanzaro Viale Europa IT 88100 Catanzaro Italy; Net4Science srl Università Magna Græcia di Catanzaro Viale Europa IT 88100 Catanzaro Italy

Experimental Bioinformatics School of Life Sciences Weihenstephan Technical University of Munich DE 85354 Munich Germany

Genetics of Cognitive Dysfunction Laboratory i3S Instituto de Investigação e Inovação em Saúde Universidade do Porto PT 4200 135 Porto Portugal; IBMC Institute for Molecular and Cell Biology Universidade do Porto PT 4200 135 Porto Portugal

i3S Instituto de Investigação e Inovação em Saúde Universidade do Porto PT 4200 135 Porto Portugal; Cancer Drug Resistance Group IPATIMUP Institute of Molecular Pathology and Immunology University of Porto PT 4200 135 Porto Portugal; Department of Biological Sciences FFUP Faculty of Pharmacy University of Porto PT 4050 313 Porto Portugal

Institut für Med Immunologie Charité Campus Virchow Klinikum DE 13353 Berlin Germany

Julius Maximilians Universität Institute for Virology and Immunobiology DE 97078 Würzburg Germany

Laboratory of Biomedical Embryology Center for Stem Cell Research UniSTEM University of Milan IT 20133 Milan Italy

Neuromuscular Disorders Biocruces Bizkaia Health Research Institute ES 48903 Barakaldo Spain; Ikerbasque Basque Foundation for Science ES 48009 Bilbao Spain

Rīga Stradiņš University Institute of Microbiology and Virology LV 1007 Riga Latvia

Satakunta University of Applied Sciences Faculty of Technology FI 26100 Rauma Finland

ScienceConsult DI Thomas Mohr KG AT 2353 Guntramsdorf Austria; Department of Medicine 1 Division Institute of Cancer Research Comprehensive Cancer Center Vienna Medical University of Vienna AT 1090 Vienna Austria

Zobrazit více v PubMed

Malik Y.S., et al. Emerging novel coronavirus (2019-nCoV)-current scenario, evolutionary perspective based on genome analysis and recent developments. Vet. Q. 2020;40:68–76. PubMed PMC

Emanueli C., et al. Call to action for the cardiovascular side of COVID-19. Eur. Heart J. 2020;41:1796–1797. PubMed PMC

Sokolovska L., et al. COVID-19: the third wave of coronavirus infection outbreak. J. Transl. Sci. 2020;7:1–5.

Palmeira A., et al. Preliminary virtual screening studies to identify GRP78 inhibitors which may interfere with SARS-CoV-2 infection. Pharmaceuticals (Basel) 2020;13:132. PubMed PMC

Artese A., et al. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses. Drug Resist. Updat. 2020 doi: 10.1016/j.drup.2020.100721. Published online August 26, 2020. PubMed DOI PMC

Sadegh S., et al. Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing. Nat. Commun. 2020;11:3518. PubMed PMC

Rasa S., et al. Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) J. Transl. Med. 2018;16:268. PubMed PMC

Turkki P., et al. Human enterovirus group B viruses rely on vimentin dynamics for efficient processing of viral nonstructural proteins. J. Virol. 2020;94 PubMed PMC

Philimonenko V.V., et al. Simultaneous detection of multiple targets for ultrastructural immunocytochemistry. Histochem. Cell Biol. 2014;141:229–239. PubMed PMC

Dunne C.P., et al. Antimicrobial coating innovations to prevent infectious disease: a consensus view from the AMiCl COST Action. J. Hosp. Infect. 2020;105:116–118. PubMed PMC

Gomes C.P.C., et al. Catalyzing transcriptomics research in cardiovascular disease: the CardioRNA COST Action CA17129. Noncoding RNA. 2019;5:31. PubMed PMC

Pennarossa G., et al. Epigenetic erasing and pancreatic differentiation of dermal fibroblasts into insulin-producing cells are boosted by the use of low-stiffness substrate. Stem Cell Rev. Rep. 2018;14:398–411. PubMed

Kadioglu O., et al. Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning. Bull. World Health Organ. 2020 doi: 10.2471/BLT.20.255943. Published online March 21, 2020. PubMed DOI PMC

Desviat L.R., et al. COST Actions: fostering collaborative research for rare diseases. Lancet Neurol. 2019;18:989–991. PubMed

Godfrey C., et al. Delivery is key: lessons learnt from developing splice-switching antisense therapies. EMBO Mol. Med. 2017;9:545–557. PubMed PMC